Effects of the angiogenesis inhibitor angiostatin on the growth of CC531 colon carcinoma cells in vitro and in a laparoscopic animal model of peritoneal carcinomatosis

International Journal of Colorectal Disease

Volumn 21, Issue 4, 2006, Pages 314-320

  Nestler, G ^a   Schulz, H U ^a   Tautenhahn, J ^a   Kuhn, R ^a   Kruger S ^a   Lippert, H ^a   Pross, M ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Angiostatin; Colon adenocarcinoma cell; Laparoscopy; Rats; Tumor growth

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER INVASION; CARCINOMA CELL; CELL ADHESION; CELL ASSAY; CELL VIABILITY; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DOSE REGIMEN; DRUG MECHANISM; EUTHANASIA; IN VITRO STUDY; IN VIVO STUDY; LAPAROSCOPIC SURGERY; NONHUMAN; PERITONEUM CANCER; PNEUMOPERITONEUM; PRIORITY JOURNAL; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; WEIGHT;

ADENOCARCINOMA; ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; CELL ADHESION; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; LAPAROSCOPY; MALE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PERITONEAL NEOPLASMS; PNEUMOPERITONEUM, ARTIFICIAL; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 33745079653     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-005-0040-2     Document Type: Article

References (32)

1. Bruch HP, Schwandner O, Schiedeck TH, Roblick UJ (1999) Actual standards and controversies on operative technique and lymph-node dissection in colorectal cancer. Langenbecks Arch Surg 384:167-175
2. Reymond MA, Schneider C, Kastl S, Hohenberger W, Kockerling F (1998) The pathogenesis of port-site recurrences. J Gastrointest Surg 2:406-414
3. Berends FJ, Kazemier G, Bonjer HJ, Lang JF (1994) Subcutaneous metastases after laparoscopic colectomy. Lancet 344:58
4. Jacobi CA, Bonjer HJ, Puttick MI, O'Sullivan R, Lee SW, Schwalbach P, Tomita H, Kim ZG, Hewett P, Wittich P, Fleshman JW, Paraskeva P, Gessman T, Neuhaus SJ, Wildbrett P, Reymond MA, Gutt C, Whelan RI (2002) Oncologic implications of laparoscopic and open surgery. Surg Endosc 16:441-445
5. Cavallaro U, Christofori G (2000) Molecular mechanisms of tumor angiogenesis and tumor progression. J Neurooncol 50:63-70
6. Folkman J (1985) Angiogenesis and its inhibitors. Important Adv Oncol 3:42-62
7. Miyoshi C, Ohshima N (2001) Vascular endothelial growth factor (VEGF) expression regulates angiogenesis accompanying tumor growth in a peritoneal disseminated tumor model. In Vivo 15:233-238
8. Yanase T, Tamura M, Fujita K, Kodama S, Tanaka K (1993) Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 53:2566-2570
9. te Velde EA, Reijerkerk A, Brandsma D, Vogten JM, Wu Y, Kranenburg O, Voest EE, Gebbink M, Borel R (2005) I: Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells. Br J Cancer 92:729-735
10. Caceres W, Gonzalez S (2003) Angiogenesis and cancer: Recent advances. P R Health Sci J 22:149-151
11. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal R, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328
12. Sim BK, MacDonald NJ, Gubish ER (2000) Angiostatin and endostatin: endogenous inhibitors of tumor growth. Cancer Metastasis Rev 19:181-190
13. Sim BK, O'Reilly MS, Liang H, Fortier AH, He W, Madsen JW, Lapcevich R, Nacy CA (1997) A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 57:1329-1334
14. Boehm T, Folkman J, Browder T, O'Reilly MS (2003) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390:404-407
15. Holmgren L, O'Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149-153
16. Mosmann T (1983) Rapid colometric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 132(1):131-138
17. Repesh LA (1989) A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 9:192-208
18. Connolly L, Maxwell P (2002) Image analysis of Transwell assays in the assessment of invasion by malignant cell lines. Br J Biomed Sci 59:11-14
19. Matsumoto G, Shindo J (2001) Cancer therapy by gene therapy with angiostatin. Drugs Today (Barc) 37:815-821
20. Prox D, Becker C, Pirie-Shepherd SR, Celik I, Folkman J, Kisker O (2003) Treatment of human pancreatic cancer in mice with angiogenic inhibitors. World J Surg 27:405-411
21. Sim BK, O'Reilly MS, Liang H, Fortier AH, He W, Madsen JW, Lapcevich R, Nacy CA (1997) A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 57:1329-1334
22. Uesato M, Gunji Y, Tomonaga T, Miyazaki S, Shiratori T, Matsubara H, Kouzu T, Shimada H, Nomura F, Ochiai T (2004) Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation. Cancer Gene Ther 11:625-632
23. Folkman J (2003) Angiogenesis and apoptosis. Semin Cancer Biol 13:159-167
24. Hanford HA, Wong CA, Kassan H, Cundiff DL, Chandel N, Underwood S, Mitchell CA, Soff GA (2003) Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells. Cancer Res 63:4275-4280
25. Beecken WD, Fernandez A, Joussen AM, Achilles EG, Flynn E, Lo KM, Gillies SD, Javaherian K, Folkman J, Shing Y (2001) Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. J Natl Cancer Inst 93:382-387
26. Bohle AS, Kalthoff H (1999) Molecular mechanisms of tumor metastasis and angiogenesis. Langenbecks Arch Surg 384:133-140
27. Lucas R, Holmgren L, Garcia I, Jimenez B, Mandriota SJ, Borlat F, Sim BK, Wu Z, Grau GE, Shing Y, Soff GA, Bouck N, Pepper MS (1998) Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 92:4730-4741
28. te Velde EA, Kusters B, Maass C, de Waal R, Borel R (2003) I: Histological analysis of defective colonic healing as a result of angiostatin treatment. Exp Mol Pathol 75:119-123
29. Dell'Eva R, Pfeffer U, Indraccolo S, Albini A, Noonan D (2002) Inhibition of tumor angiogenesis by angiostatin: From recombinant protein to gene therapy. Endothelium 9:3-10
30. Gastl G, Hermann T, Steurer M, Zmija J, Gunsilius E, Unger C, Kraft A (1997) Angiogenesis as a target for tumor treatment. Oncology 54:177-184
31. Beerepoot LV, Witteveen EO, Groenewegen G, Fogler WE, Sim BK, Sidor C, Zonnenberg BA, Schramel F, Gebbink MF, Voest EE (2003) Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: A pharmacokinetic and long-term safety study. Clin Cancer Res 9:4025-4033
32. Peeters CF, de Geus LF, Westphal JR, de Waal RM, Ruiter DJ, Wobbes T, Oyen WJ, Ruers TJ (2005) Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases. Surgery 137:246-249